DEA Registration Window Opens: What Cannabis Operators and Investors Must Do Next

A critical window has opened for medical cannabis companies in the United States—and what happens in the next 60 days could shape competitive positioning for years.

Following the formal publication of the Attorney General’s rescheduling order on April 28, state-legal medical cannabis operators can now apply for DEA Schedule III registration, with applications opening April 29 at 9 a.m.

Companies that apply within 60 days will qualify for an expedited six-month review process and will be treated as Schedule III-compliant while their applications are pending.

To understand what this means in practice, IgniteIt spoke with Lauren Rudick and Fatima Afia, cannabis attorneys at Rudick Law Group, who are advising operators on how to navigate the transition.

What the Rescheduling Order Actually Covers

Despite market excitement, Rudick and Afia say one of the biggest risks right now is misunderstanding the scope of the change.

“One of the most significant misconceptions we’re seeing is that rescheduling equals legalization—it simply does not,” they said.

Immediate Schedule III status applies only to:

FDA-approved cannabis drugs
State-licensed medical marijuana and extracts
Naturally derived delta-9 THC within those categories

“Others are under the equally misguided impression that all cannabis has now been rescheduled to Schedule III—it has not,” they added.

Adult-use cannabis remains a Schedule I substance, and broader classification changes will not be addressed until the DEA hearings scheduled from June 29 to July 15.

Why Operators Are Being Urged to Act Quickly

For medical cannabis companies, the clock is already running.

“If registration with the DEA is completed within 60 days of the Order’s publication, companies qualify for an expedited review and determination process,” Rudick and Afia explained.

That timing could unlock:

Early access to supply chain partners
Priority positioning in regulatory queues
A potential first-mover advantage

But speed comes with trade-offs.

“Being first to market isn’t always best, particularly in an environment where the regulatory landscape is still taking shape,” they cautioned, noting that federal registration could “shine a spotlight on existing liabilities and legal exposure.”

“The speed at which any company moves to register should reflect its own risk tolerance and strategic posture.”

Compliance Starts With Fundamentals

Before applying, the attorneys emphasize that operators need to focus on foundational compliance.

“The most important thing cannabis operators can do right now isn’t glamorous—it’s foundational,” they said.

That includes:

Reviewing corporate governance documents
Clarifying roles and decision-making authority
Auditing SOPs to ensure they reflect current operations
Evaluating criminal history disclosures for key personnel
Ensuring strict compliance with state law

“Any gaps between your SOPs and your actual operations could be a liability,” they warned.

As federal frameworks develop, regulators are expected to use state-level compliance as a key benchmark.

Investors and Capital Markets: A Changing Risk Profile

The shift to Schedule III is also changing how investors evaluate the sector.

“The risk calculus for investors and B2B service providers has shifted meaningfully,” Rudick and Afia said.

They point to:

State-licensed medical operators
Testing labs and ancillary services
Genetics companies and breeders

as being “best positioned to benefit from the current regulatory trajectory.”

At the same time, potential 280E tax relief could significantly improve free cash flow and open access to institutional capital.

“That means operators will have a meaningfully easier time returning capital to investors than they have in the past,” they said.

Strategy at the C-Suite Level: Move Carefully

Despite the urgency, the attorneys stress that this is not a moment for rushed decisions.

“The most important discipline a leadership team can exercise right now is humility,” they said.

“We are operating in a period of genuine regulatory incompleteness.”

Leadership teams should:

Avoid irreversible commitments
Build flexibility into strategy
Stress-test decisions across multiple scenarios

“The leaders who will fare best are not those who move fastest—they are those who move most thoughtfully, with eyes wide open to what they don’t yet know.”

A Narrow Window, With Broad Implications

With the 60-day clock already running, operators now face a critical decision: move early and potentially gain an advantage, or wait for more clarity and reduce exposure.

“The window to get ahead of this shift is now,” Rudick and Afia said.

But as the attorneys make clear, success in this transition will depend not just on timing, but on execution.